These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY. Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547 [Abstract] [Full Text] [Related]
3. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY. Hypertension; 2011 Feb 17; 57(2):314-22. PubMed ID: 21189404 [Abstract] [Full Text] [Related]
4. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways. Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ. Clin Exp Pharmacol Physiol; 2009 Mar 17; 36(3):287-96. PubMed ID: 19018797 [Abstract] [Full Text] [Related]
9. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats. Javkhedkar AA, Lokhandwala MF, Banday AA. Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F47-51. PubMed ID: 21900450 [Abstract] [Full Text] [Related]
10. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats. Saha S, Li Y, Anand-Srivastava MB. Can J Physiol Pharmacol; 2008 Apr 01; 86(4):190-8. PubMed ID: 18418428 [Abstract] [Full Text] [Related]
12. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats. Kirimura K, Takai S, Jin D, Muramatsu M, Kishi K, Yoshikawa K, Nakabayashi M, Mino Y, Miyazaki M. Hypertens Res; 2005 May 01; 28(5):457-64. PubMed ID: 16156510 [Abstract] [Full Text] [Related]
14. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system. Nagata S, Kato J, Kuwasako K, Asami M, Kitamura K. Hypertens Res; 2012 Feb 01; 35(2):234-8. PubMed ID: 21993212 [Abstract] [Full Text] [Related]
16. Regulation of myosin light chain kinase expression by angiotensin II in hypertension. Han YJ, Hu WY, Piano M, de Lanerolle P. Am J Hypertens; 2008 Aug 01; 21(8):860-5. PubMed ID: 18511912 [Abstract] [Full Text] [Related]
17. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2. Patel VB, Takawale A, Ramprasath T, Das SK, Basu R, Grant MB, Hall DA, Kassiri Z, Oudit GY. J Mol Med (Berl); 2015 Sep 01; 93(9):1003-13. PubMed ID: 25874965 [Abstract] [Full Text] [Related]
18. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY. Mueller SM, Cohen ML. Artery; 1985 Sep 01; 12(6):337-45. PubMed ID: 2996465 [Abstract] [Full Text] [Related]
19. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. Gowrisankar YV, Clark MA. J Neurochem; 2016 Jul 01; 138(1):74-85. PubMed ID: 27085714 [Abstract] [Full Text] [Related]